Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

Biogen to Spin Off Hemophilia Unit, Focus on Neurodegenerative Drugs

May 4, 2016 | by Stephanie Guzowski, Editor | News | Comments

Biogen announced the company plans to spin off its hemophilia drug business as a publicly traded company, and instead concentrate on developing treatments for neurodegenerative diseases, primarily multiple sclerosis (MS). The move is surprising analysts.

TOPICS:

Takeda's Brintellix Renamed Trintellix

May 4, 2016 3:00 pm | News | Comments

The formulation, indication and dosages of Trintellix remain the same as that of Brintellix.

TOPICS:

Searching for Signs of Disease in Spit

May 4, 2016 2:00 pm | by American Chemical Society | News | Comments

Testing for health conditions usually involves needles, X-rays and other invasive or uncomfortable measures.

TOPICS:

Nano-Capsules Promise Targeted Drug Delivery

May 4, 2016 1:00 pm | by Lomonosov Moscow State University | News | Comments

Synthesis of the nanogel capsules and the related measurements were conducted in Europe.

TOPICS:
Advertisement

New Insight into Autoimmune Disorder Sjögren's Syndrome

May 4, 2016 9:52 am | by American Physiological Society | News | Comments

Researchers from the University of Southern California (USC) Roski Eye Institute believe that distinct changes in the composition of tears may occur before tear production lessens.

TOPICS:

African Leaders Step Up to Narrow Immunization Gap

May 4, 2016 8:46 am | by Charles Wysonge, Stellenbosch University, The Conversation | News | Comments

Six of the ten countries that are home to 60 percent of unvaccinated children in the world are in Africa.

TOPICS:

Another Big Verdict in Talc Case Against J&J

May 4, 2016 8:46 am | by Jim Salter, Associated Press | News | Comments

The medical community hasn't reached a consensus on talc as a possible carcinogen.

TOPICS:

Research Points to New Pancreatic Cancer Treatment

May 4, 2016 8:46 am | by Purdue University | News | Comments

Researchers have shown how controlling cholesterol metabolism in pancreatic cancer cells reduces metastasis.

TOPICS:

Faster, Cheaper Way to Produce New Antibiotics

May 4, 2016 8:42 am | by University of Bristol | News | Comments

With resistance growing to existing antibiotics, there is a vital and urgent need for the discovery and development of new antibiotics that are cost effective.

TOPICS:
Advertisement

Herbal Remedies Are an Overlooked Global Health Hazard

May 4, 2016 8:30 am | by Baylor College of Medicine | News | Comments

Millions of people around the world use herbal health remedies, following a tradition that began millennia ago.

TOPICS:

Side Effects of Statins Investigated in New £1M Trial

May 4, 2016 7:30 am | by London School of Hygiene & Tropical Medicine | News | Comments

Many patients stop taking statins due to less severe symptoms, such as muscle pain or fatigue.

TOPICS:

Investigational Compound Shows Promise Against Melanoma, Lymphoma

May 3, 2016 3:00 pm | by UNC Chapel Hill | News | Comments

The specific mutation of EZH2 is a relatively common event in diverse cancers.

TOPICS:

Asthma Linked to DNA Damage

May 3, 2016 2:00 pm | by Anne Trafton, MIT News Office | News | Comments

The research team focused on dust-mite-induced allergies because dust mites are ubiquitous and thrive in warm, humid climates.

TOPICS:

Pfizer Tops Street 1Q Forecasts on Higher Sales, Lower Taxes

May 3, 2016 1:30 pm | by Linda A. Johnson, AP Business Writer | News | Comments

The company raised its 2016 financial forecasts, citing the strong quarter and an improved business outlook.

TOPICS:

Ebola Vaccine: Promising Phase 1 Trials

May 3, 2016 1:00 pm | by German Center for Infection Research | News | Comments

Across the four locations, a total of 158 healthy volunteers were vaccinated with increasing doses of the potential vaccine

TOPICS:

Experimental Alzheimer's Drug Reverses Disease's Genetic Changes

May 3, 2016 10:07 am | by Rockefeller University | News | Comments

In new research described recently in Molecular Psychiatry, a team led by Ana Pereira, instructor in clinical medicine in Bruce McEwen's laboratory, found that the drug, riluzole, is capable of reversing key genetic changes associated with these conditions.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading